MedPath

Treatment of infertility in Ayurveda

Phase 2
Recruiting
Conditions
Tubal factor in Female Infertility
Registration Number
CTRI/2017/01/007664
Lead Sponsor
IPGT and RA
Brief Summary

1 Deepan pachana with aampachana Vati and then Kostha shodhana with Eranda Bhrishta Haritaki 

2 5ml uttarabasti of apamarga ksharataila for 3 days

3 After the gap of 3 days, 5 ml Phalakalyana Ghrita Uttarabasti once in a day for 3 days.

This Protocol will be follow for 3 consecutive cycle.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Female
Target Recruitment
30
Inclusion Criteria

1 Patients of childbearing age (20-37yrs) with active marital life of 1 year or more, having complaint of failure to conceive with at least one fallopian Tube blocked diagnosed by H.S.G. 2 Having seminogram within normal limit of male partner.(>20 million/ml).

Exclusion Criteria

1 Patients having age group below 20 years & above 37 years 2 Patients having any acute pelvic infection, hypersensitivity to chemical dye, congenital anomalies of vulva & vagina, Ca cervix, STD or any debilitating disease like TB, HIV, VDRL, HBsAg and TORCH positive will be excluded from study 3)Patients suffering from infertility due to male factor ie Oligospermia, Oligozoospermia, Azoospermia, Asthanospermia also be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Uttarabasti of Apamarga Kshara Taila and Phalkalyana Ghrita is highly effective in management of Female Infertility wsr to Tubal blockage.3 month
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of streerog and prasutitantra IPGTRA Hospital Jamnagar Gujarat

🇮🇳

Jamnagar, GUJARAT, India

Department of streerog and prasutitantra IPGTRA Hospital Jamnagar Gujarat
🇮🇳Jamnagar, GUJARAT, India
Dr Sunil Patidar
Principal investigator
9981092007
sunilpatidar029@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.